Konstantakopoulou C and Verykokakis M (2024). Key functions of the transcription factor Bcl6 during T cell development, Adv Exp Med Biol. 2024;1459:79-94. doi: 10.1007/978-3-031-62731-6_4
Editorial: Transcriptional and epigenetic control of T and innate lymphoid cell development and function. Xu W and Verykokakis M, Front Immunol. 2023 May 11;14:1213831.
Innate-like T lymphocytes in chronic liver disease. Papanastasatou M and Verykokakis M, Front Immunol. 2023 Mar 15;14:1114605
UT(se)X differences during immune responses. Galaras A and Verykokakis M, Nat Immunol. 2023 May;24(5):738-740.
Carr T, McGregor SM, Dias S, Verykokakis M, Lebeau MM, Xue H-H, Bartom ET, Kee BL (2022). Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/-T Acute Lymphoblastic Leukemia. Frontiers in Immunology., 2022 Mar 18;13:845488
Gioulbasani M, Galaras A, Grammenoudi S, Moulos P, Dent A, Sigvardsson M, Hatzis P, Kee BL, and Verykokakis M (2020). The transcription factor BCL6 controls early development of innate-like T cells. Nature Immunology Sep;21(9):1058-1069)
Verykokakis M and Kee BL (2018). Transcriptional and epigenetic regulation of innate-like T lymphocyte development. Curr Opin Immunol Apr 51:39-45
Zook EC, Li ZY, Xu Y, de Pooter RF, Verykokakis M, Beaulieu A, Lasorella A, Maienschein-Cline M, Sun JC, Sigvardsson M, Kee BL (2018). Transcription factor ID2 prevents E proteins from enforcing a naïve T lymphocyte gene program during NK cell development. Science Immunol Apr 27;3(22). pii: eaao2139
Verykokakis M.*, Kee B.L.* (2017): Applying the TOR(C)QUE in iNKT cells: A new twist in an old tale. European Journal of Immunology Eur J Immunol, Mar 47 (3): 454-457 *corresponding authors
Carr T., Krishnamoorthy V., Yu S., Xue H.H., Kee B.L.*, Verykokakis M* (2015): The transcription factor lymphoid enhancer factor 1 controls invariant natural killer T cell expansion and Th2-type effector differentiation. Journal of Experimental Medicine 2015, May 4;212(5):793-807 *corresponding authors
Verykokakis M., Zook E., Kee B.L. (2014): ID’ing Innate and Innate-like Lymphoid Cells. Immunological Reviews. 2014 Sep;261(1):177-97
Verykokakis M*, Krishnamoorthy V, Iavarone A, Lasorella A, Sigvardsson M, Kee B.L.* (2013) Essential functions for ID proteins at multiple checkpoints in invariant NKT cell development. Journal of Immunology 2013, Dec 15;191(12): 5973-83 *corresponding authors
Verykokakis M., Boos M.D., Bendelac A., Kee B.L. (2010) SAP protein-dependent natural killer T-like cells regulate the development of CD8(+) T cells with innate lymphocyte characteristics. Immunity 2010 Aug 27; 33(2):203-215
•Commented by: Minton K. (2010): NKT cells favour the unconventional. Nature Rev Immunol 2010 Sep;10(9):618
Verykokakis M., Boos M.D., Bendelac A., Adams E.J., Pereira P., Kee B.L. (2010) Inhibitor of DNA Binding 3 Limits Development of Murine Slam-Associated Adaptor Protein-Dependent “Innate” γδ T cells. PLoSONE 2010 5(2): e9303
Verykokakis M., Papadaki C., Vorgia E., LeGallic L., Mavrothalassitis G. (2007) The Erf control of cell proliferation and differentiation is mediated by c-Myc transcriptional repression. Journal of Biological Chemistry 2007 Oct 12; 282(41), 30285-30294
Papadaki C., Alexiou M, Cecena G., Verykokakis M., Bilitou K., Cross J.C., Oshima R.G., Mavrothalssitis G. (2007) The Transcriptional Repressor Erf Determines Extraembryonic Ectoderm Differentiation. Molecular and Cellular Biology 2007 Jul;27(14):5201-13
Polychronopoulos S., Verykokakis M., Yazicioglu M.N., Sakarellos-Daitsiotis M., Cobb M.H. and Mavrothalassitis G. (2006). The transcriptional ETS2 repressor factor associates with active and inactive Erks through distinct FXF motifs. Journal of Biological Chemistry 2006 Sep 1; 281(35), 25601-25611
Books
Principles of Genetics by Snustad and Simmons, 7th Edition: Eleni Vastardis, Galinos Fanourakis, Pantelis Hatzis, Mihalis Verykokakis. Editor for the Greek edition